title: Clinical characterization and immunopathologic features of sclerosing dacryoadenitis and riedel thyroiditis.
authors.affiliation: David G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear Infirmary, Boston, 02114, USA. fred_jakobiec@meei.harvard.edu
authors.forename: Frederick A
authors.initials: FA
authors.lastname: Jakobiec
authors.forename: Rebecca C
authors.initials: RC
authors.lastname: Stacy
authors.forename: Mark P
authors.initials: MP
authors.lastname: Hatton
mesh_terms: D000328:Adult; D001402:B-Lymphocytes / Q000276:immunology; D003607:Dacryocystitis / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D004359:Drug Therapy, Combination; D004804:Eosinophils / Q000276:immunology; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007124:Immunoenzyme Techniques; D007074:Immunoglobulin G / Q000097:blood; D007765:Lacrimal Apparatus / Q000473:pathology*; D010950:Plasma Cells / Q000276:immunology; D012598:Sclerosis; D013601:T-Lymphocytes / Q000276:immunology; D013629:Tamoxifen / Q000627:therapeutic use; D013966:Thyroiditis / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D013974:Thyroxine / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed
chemical_list: D005938:Glucocorticoids; D007074:Immunoglobulin G; D013629:Tamoxifen; D013974:Thyroxine